Physician profile
Neil Mehta
NPI 1588605695
$566.86
in general payments reported to CMS, 2019-2025
11 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.80 · 2020: $40.13 · 2021: $100 · 2023: $73.67 · 2024: $63.38 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioprotect Medical, INC. | $147.43 | 2025 | Bioprotect Balloon Implant System |
| Glaxosmithkline, LLC. | $100.00 | 2021 | |
| Blue Earth Diagnostics | $55.07 | 2025 | Posluma |
| Merck Sharp & Dohme LLC | $51.70 | 2019-2025 | Bridion |
| Gilead Sciences, INC. | $46.90 | 2023-2024 | |
| Boston Scientific Corporation | $41.42 | 2024 | Wallflex Duodenal |
| Janssen Biotech, INC. | $32.96 | 2025 | Erleada |
| Amgen INC. | $29.66 | 2023 | Lumakras |
| Eisai INC. | $24.79 | 2020 | |
| Verity Pharmaceuticals INC. | $19.07 | 2023 | Trelstar |
| Tactile Systems Technology INC | $17.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.